Navigation Links
Dyadic International Introduces Advanced Biofuels Enzyme AlternaFuel® CMAX™ At World Biofuels Markets
Date:3/22/2011

JUPITER, Fla., March 22, 2011 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today the introduction of its most advanced biofuels enzyme, AlternaFuel® CMAX™, at the World Biofuels Markets exhibition in Rotterdam, The Netherlands.

(Logo: http://photos.prnewswire.com/prnh/20091214/DYADICLOGO)

Dyadic has recently completed its scale-up of AlternaFuel® CMAX™ which was derived from Dyadic's proprietary and patented C1 platform technology. AlternaFuel® CMAX™ has proven to be effective in converting multiple forms of biomass into fermentable sugars which is the critical step in the production of cellulosic ethanol and other advanced biofuels and biochemicals from non-food feedstocks.

The World Biofuels Markets is Europe's largest biofuels congress and exhibition, supporting the world's development and search for alternative energy sources. All attendees of the World Biofuels Markets are welcome to visit Dyadic's stand located at Booth #9 where Dyadic's leading scientists will be available to discuss specific applications of AlternaFuel® CMAX™.

Dyadic's President and CEO, Mark Emalfarb, will also be presenting the most recent data regarding the performance of AlternaFuel® CMAX™ at the World Biofuels Markets on Wednesday, March 23rd at the Biobased Chemicals session and on Thursday, March 24th at the Advanced Biofuels session.

Mr. Emalfarb stated, "Dyadic has always maintained that the best economic model for the efficient production of cellulosic sugars involves controlling the enzyme technology necessary for the on-site production of biofuels and biochemicals. The decision to make AlternaFuel® CMAX™ commercially available supports this goal by providing prospective partners with greater access to these unique enzymes in a ready-to-use formulation so that they can observe their performance and flexibility in demonstrations at their own facilities. We believe that this will not only provide additional revenue to Dyadic through product sales but will also provide greater opportunity for these customers to transition from purchasing these enzymes to ultimately manufacturing them on-site under license from Dyadic."

About Dyadic

Dyadic International, Inc. is a global biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, industrial enzyme and biopharmaceutical industries.

Cautionary Statement for Forward-Looking Statements

Certain statements contained in this press release are forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause Dyadic's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Except as required by law, Dyadic expressly disclaims any intent or obligation to update any forward-looking statements.

For more information on AlternaFuel® CMAX™, please visit Dyadic's website at www.dyadic.com and contact:

Thomas M. O'Shaughnessy
Vice President Sales & Marketing
Dyadic International, Inc.
Phone: 561-743-8333
Email: enzymes@dyadic.com


'/>"/>
SOURCE Dyadic International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Dyadic International Reports 2010 Fiscal Year Financial Results
2. Dyadic International Launches High Performance Enzyme for Pulp and Paper Industry Using New C1 Production Platform
3. Dyadic International Reports 2010 Third Quarter Financial Results
4. Dyadic International to Announce Third Quarter 2010 Financial Results and Hold Conference Call on November 15, 2010
5. Dyadic International Raises $3 Million in Private Placement of Convertible Notes
6. Dyadic International to Announce Second Quarter 2010 Financial Results and Hold Conference Call on August 13, 2010
7. Dyadic International Announces Final Resolution and Dismissal of Stockholder Class Action Lawsuit
8. Dyadic International Engages The Abraham Group as Strategic Advisor
9. Dyadic International to Present at Rodman & Renshaw 6th Annual Global Healthcare Conference
10. Dyadic International Strengthens Management Team
11. Dyadic International Extends Collaboration With The Scripps Research Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... Ellen ... the Connecticut Technology Council (CTC) as a 2017 Women of Innovation® finalist. Matloff ... of Innovation Awards Dinner. , The dinner recognizes women accomplished in science, technology, ...
(Date:3/23/2017)... , March 23, 2017 According to a ... and derivatives market is fragmented due to the presence of a large ... Proliant, Thermo Fisher , and Sigma-Aldrich, compete with each other ... companies, collectively, held more than 76% of this market in 2016.  ... As of now, ...
(Date:3/23/2017)... La. (PRWEB) , ... March 23, 2017 , ... ... industrial monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as ... customer applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career has ...
(Date:3/22/2017)... 2017  Ascendis Pharma A/S (Nasdaq: ASND), a ... to address significant unmet medical needs in rare ... year ended December 31, 2016. ... as we broadened our pipeline and pursued our ... company with an initial focus on endocrinology," said ...
Breaking Biology Technology:
(Date:3/9/2017)... March 9, 2017 4Dx has publicly released ... Imaging Workshop at the University of Pennsylvania. Founder and ... deliver the latest data to world leaders in lung ... together leaders at the forefront of the industry to ... "The quality of the imaging is ...
(Date:3/2/2017)... , March 2, 2017 Summary ... understand Perrigo and its partnering interests and activities since 2010. ... Read ... Deals and Alliance since 2010 report provides an in-depth insight ... life sciences companies. On demand company reports are ...
(Date:2/28/2017)... ANGELES , Feb. 28, 2017   Acuant ... verification software globally, announces significant enhancements to new and ... May 2016. New products include mobile and desktop Acuant ... DocX TM - a real time manual review ... core idScan® technology provides the fastest and most accurate ...
Breaking Biology News(10 mins):